Qinec Appoints Jim Horsburgh as Chairman - Gilde Healthcare

Qinec Appoints Jim Horsburgh as Chairman

December 8, 2015

Industry veteran joins digital health company

LONDON – Qinec, a digital health company focused on cloud based Personalised Healthcare Management, today announced that healthcare IT veteran Jim Horsburgh has joined Qinec’s board as a non executive member and been appointed as independent chairman.

Robbie Hughes, CEO at Qinec said:

“Qinec’s Personalised Healthcare Management platform has been adopted by many of the UK’s largest commercial healthcare providers. Jim’s expertise as a chairman of numerous digital health companies will be invaluable in guiding Qinec through the next stage of growth.”

Jim previously served as Chairman of healthcare IT company System C, leading the company through its successful IPO and acquisition by McKesson. He also served as SVP Worldwide Marketing at Visio through its IPO and acquisition by Microsoft, and in business development and marketing roles at CentralPoint Software, Lotus and Olivetti. Jim currently serves as chairman for Insource, a data warehousing automation solution specialising in healthcare, and chairman for Shearwater, a developer of mobile solutions for healthcare. He’s previously served as chairman for ScriptSwitch Ltd. and Triaster Ltd.

Jim Horsburgh said:

“Qinec has had a huge impact on healthcare, challenging the legacy, siloed mentality of healthcare IT by focusing its approach on the orchestration of the patient journey. Qinec has established itself as a trusted agent of change within the industry; its proposition is compelling for patients, providers and payers alike.”

About Qinec

Qinec is a UK-based digital health company providing Personalized Healthcare Management (PHM) solutions. The company’s cloud-based SaaS platform uses real time data to orchestrate the patient journey to achieve optimal outcomes for patients, providers and payers at lower cost. Managing millions of patients a year across Europe, Qinec tailors processes and optimizes clinical and administrative workflows across every specialty of outpatient care. For more information about Qinec please visit www.qinec.com.

Press Contact:

Michele Moore
PR Manager
+44 07507 246 961
Michele.Moore@qinec.com

Gilde Healthcare company CatalYm announces leadership changes to accelerate visugromab late-stage clinical development

Gilde Healthcare company CatalYm, a world-leader in neutralizing GDF-15 in cancer and cachexia, today announced changes to its executive leadership team to support its next stage of growth. The appointments of Clinton Musil as Chief...
September 15, 2025

Gilde Healthcare company Tagworks Pharmaceuticals Announces Initiation of Third Dose Level in Ongoing Phase 1 Clinical Trial of TGW101 for the Treatment of Solid Tumors

TGW101 is a next-generation, first-in-class ADC targeting TAG-72 with an MMAE payload, developed based on Tagworks proprietary Click-to-Release linker chemistry; TGW101 is the first bioorthogonal, in vivo click chemistry-activated ADC, which enables superior control of tumor...
September 10, 2025

Gilde Healthcare appoints Dr. Christian Stark as Group CEO of its globally operating medical technology group

The medical technology group, which includes two manufacturers of surgical instruments in the Tuttlingen region, Koscher & Würtz and Christian Diener, has appointed Dr. Christian Stark as Chief Executive Officer (CEO) with effect from September...
September 3, 2025